181 related articles for article (PubMed ID: 11714842)
1. Role of apoA-II in lipid metabolism and atherosclerosis: advances in the study of an enigmatic protein.
Blanco-Vaca F; Escolà-Gil JC; Martín-Campos JM; Julve J
J Lipid Res; 2001 Nov; 42(11):1727-39. PubMed ID: 11714842
[TBL] [Abstract][Full Text] [Related]
2. Expression of human apolipoprotein A-II in apolipoprotein E-deficient mice induces features of familial combined hyperlipidemia.
Escolà-Gil JC; Julve J; Marzal-Casacuberta A; Ordóñez-Llanos J; González-Sastre F; Blanco-Vaca F
J Lipid Res; 2000 Aug; 41(8):1328-38. PubMed ID: 10946021
[TBL] [Abstract][Full Text] [Related]
3. Human apolipoprotein A-II enrichment displaces paraoxonase from HDL and impairs its antioxidant properties: a new mechanism linking HDL protein composition and antiatherogenic potential.
Ribas V; Sánchez-Quesada JL; Antón R; Camacho M; Julve J; Escolà-Gil JC; Vila L; Ordóñez-Llanos J; Blanco-Vaca F
Circ Res; 2004 Oct; 95(8):789-97. PubMed ID: 15388641
[TBL] [Abstract][Full Text] [Related]
4. Atherosclerosis in transgenic mice overexpressing apolipoprotein A-II.
Warden CH; Hedrick CC; Qiao JH; Castellani LW; Lusis AJ
Science; 1993 Jul; 261(5120):469-72. PubMed ID: 8332912
[TBL] [Abstract][Full Text] [Related]
5. Paradoxical exacerbation of combined hyperlipidemia in human apolipoprotein A-II transgenic mice treated with fenofibrate.
Ribas V; Palomer X; Roglans N; Rotllan N; Fievet C; Tailleux A; Julve J; Laguna JC; Blanco-Vaca F; Escolà-Gil JC
Biochim Biophys Acta; 2005 Dec; 1737(2-3):130-7. PubMed ID: 16226489
[TBL] [Abstract][Full Text] [Related]
6. Expression of human apolipoprotein A-I/C-III/A-IV gene cluster in mice induces hyperlipidemia but reduces atherogenesis.
Vergnes L; Baroukh N; Ostos MA; Castro G; Duverger N; Nanjee MN; Najib J; Fruchart JC; Miller NE; Zakin MM; Ochoa A
Arterioscler Thromb Vasc Biol; 2000 Oct; 20(10):2267-74. PubMed ID: 11031214
[TBL] [Abstract][Full Text] [Related]
7. Decreased susceptibility to diet-induced atherosclerosis in human apolipoprotein A-II transgenic mice.
Tailleux A; Bouly M; Luc G; Castro G; Caillaud JM; Hennuyer N; Poulain P; Fruchart JC; Duverger N; Fiévet C
Arterioscler Thromb Vasc Biol; 2000 Nov; 20(11):2453-8. PubMed ID: 11073852
[TBL] [Abstract][Full Text] [Related]
8. Human ApoA-II inhibits the hydrolysis of HDL triglyceride and the decrease of HDL size induced by hypertriglyceridemia and cholesteryl ester transfer protein in transgenic mice.
Zhong S; Goldberg IJ; Bruce C; Rubin E; Breslow JL; Tall A
J Clin Invest; 1994 Dec; 94(6):2457-67. PubMed ID: 7989603
[TBL] [Abstract][Full Text] [Related]
9. Functional lecithin:cholesterol acyltransferase deficiency and high density lipoprotein deficiency in transgenic mice overexpressing human apolipoprotein A-II.
Marzal-Casacuberta A; Blanco-Vaca F; Ishida BY; Julve-Gil J; Shen J; Calvet-Márquez S; González-Sastre F; Chan L
J Biol Chem; 1996 Mar; 271(12):6720-8. PubMed ID: 8636092
[TBL] [Abstract][Full Text] [Related]
10. Apolipoprotein A-II and adiponectin as determinants of very low-density lipoprotein apolipoprotein B-100 metabolism in nonobese men.
Chan DC; Watts GF; Ooi EM; Chan DT; Wong AT; Barrett PH
Metabolism; 2011 Oct; 60(10):1482-7. PubMed ID: 21550083
[TBL] [Abstract][Full Text] [Related]
11. ApoA-II expression in CETP transgenic mice increases VLDL production and impairs VLDL clearance.
Escolà-Gil JC; Julve J; Marzal-Casacuberta A; Ordóñez-Llanos J; González-Sastre F; Blanco-Vaca F
J Lipid Res; 2001 Feb; 42(2):241-8. PubMed ID: 11181754
[TBL] [Abstract][Full Text] [Related]
12. Increased production of very-low-density lipoproteins in transgenic mice overexpressing human apolipoprotein A-II and fed with a high-fat diet.
Julve J; Escolà-Gil JC; Marzal-Casacuberta A; Ordóñez-Llanos J; González-Sastre F; Blanco-Vaca F
Biochim Biophys Acta; 2000 Nov; 1488(3):233-44. PubMed ID: 11082533
[TBL] [Abstract][Full Text] [Related]
13. Effects of apoA-V on HDL and VLDL metabolism in APOC3 transgenic mice.
Qu S; Perdomo G; Su D; D'Souza FM; Shachter NS; Dong HH
J Lipid Res; 2007 Jul; 48(7):1476-87. PubMed ID: 17438339
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of action of a peroxisome proliferator-activated receptor (PPAR)-delta agonist on lipoprotein metabolism in dyslipidemic subjects with central obesity.
Ooi EM; Watts GF; Sprecher DL; Chan DC; Barrett PH
J Clin Endocrinol Metab; 2011 Oct; 96(10):E1568-76. PubMed ID: 21816786
[TBL] [Abstract][Full Text] [Related]
15. ApoA-IHelsinki (Lys107-->0) associated with reduced HDL cholesterol and LpA-I:A-II deficiency.
Tilly-Kiesi M; Zhang Q; Ehnholm S; Kahri J; Lahdenperä S; Ehnholm C; Taskinen MR
Arterioscler Thromb Vasc Biol; 1995 Sep; 15(9):1294-306. PubMed ID: 7670941
[TBL] [Abstract][Full Text] [Related]
16. Protein composition determines the anti-atherogenic properties of HDL in transgenic mice.
Schultz JR; Verstuyft JG; Gong EL; Nichols AV; Rubin EM
Nature; 1993 Oct; 365(6448):762-4. PubMed ID: 8413656
[TBL] [Abstract][Full Text] [Related]
17. In vivo metabolism of ApoB, ApoA-I, and VLDL triglycerides in a form of hypobetalipoproteinemia not linked to the ApoB gene.
Elias N; Patterson BW; Schonfeld G
Arterioscler Thromb Vasc Biol; 2000 May; 20(5):1309-15. PubMed ID: 10807747
[TBL] [Abstract][Full Text] [Related]
18. Studies with apolipoprotein A-II transgenic mice indicate a role for HDLs in adiposity and insulin resistance.
Castellani LW; Goto AM; Lusis AJ
Diabetes; 2001 Mar; 50(3):643-51. PubMed ID: 11246886
[TBL] [Abstract][Full Text] [Related]
19. Human apolipoproteins A-I and A-II in cell cholesterol efflux: studies with transgenic mice.
Chiesa G; Parolini C; Canavesi M; Colombo N; Sirtori CR; Fumagalli R; Franceschini G; Bernini F
Arterioscler Thromb Vasc Biol; 1998 Sep; 18(9):1417-23. PubMed ID: 9743230
[TBL] [Abstract][Full Text] [Related]
20. ApoA-II maintains HDL levels in part by inhibition of hepatic lipase. Studies In apoA-II and hepatic lipase double knockout mice.
Weng W; Brandenburg NA; Zhong S; Halkias J; Wu L; Jiang XC; Tall A; Breslow JL
J Lipid Res; 1999 Jun; 40(6):1064-70. PubMed ID: 10357838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
